Kyverna Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2023 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Kyverna Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2023 to Q4 2024.
  • Kyverna Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2024 was 38.3M shares, a 5591% increase year-over-year.
  • Kyverna Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 38.3M shares, a 5591% increase from 2023.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 38.3M +37.7M +5591% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-27
Q3 2024 43.2M +42.5M +6393% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 43.1M +42.5M +6772% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 23.8M +22.8M +2478% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 674K Oct 1, 2023 Dec 31, 2023 10-K 2025-03-27
Q3 2023 665K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 628K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 921K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.